Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05432401
Status:
RECRUITING
Last Update Posted:
2022-06-27
First Post:
2022-06-10
Brief Title:
TAA05 Injection in the Treatment of Adult Patients With FLT3-positive RelapsedRefractory Acute Myeloid Leukemia
Sponsor:
PersonGen BioTherapeutics Suzhou Co Ltd
Organization:
PersonGen BioTherapeutics Suzhou Co Ltd
Organization Data
Organization:
PersonGen BioTherapeutics Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
PG-pCART-TAA05-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PersonGen BioTherapeutics Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None